lysophosphatidic acid has been researched along with Neoplasms, Cystic, Mucinous, and Serous in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catane, LJ; Davidson, B; Hetland Falkenthal, TE; Onallah, H; Reich, R; Tropé, CG | 1 |
| Asafova, A; Brandt, DT; Finkernagel, F; Graumann, J; Grosse, R; Jansen, JM; Konzer, A; Lieber, S; Müller, R; Müller-Brüsselbach, S; Nist, A; Nockher, WA; Pesek, J; Reinartz, S; Stiewe, T; Wagner, U; Watzer, B; Worzfeld, T | 1 |
| Hanousek, L; Sedláková, I; Tošner, J; Vávrová, J | 1 |
3 other study(ies) available for lysophosphatidic acid and Neoplasms, Cystic, Mucinous, and Serous
| Article | Year |
|---|---|
Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma; Disease-Free Survival; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Kaplan-Meier Estimate; Lysophospholipids; Middle Aged; Multivariate Analysis; Neoplasm Grading; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Phosphoric Diester Hydrolases; Phosphorylation; Proportional Hazards Models; Proto-Oncogene Proteins c-akt; Receptors, Lysophosphatidic Acid; Risk Factors; RNA, Messenger; Signal Transduction; Time Factors; Treatment Outcome | 2018 |
Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment.
Topics: Ascites; Cell Line, Tumor; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Lysophospholipids; Macrophages; Metabolome; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Receptors, Lysophosphatidic Acid; Signal Transduction; Treatment Outcome; Tumor Microenvironment; Up-Regulation | 2019 |
Lysophosphatidic acid (LPA)—a perspective marker in ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Case-Control Studies; Female; Humans; Lysophospholipids; Middle Aged; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Retrospective Studies; Sensitivity and Specificity | 2011 |